HealthEquity

Colombia's Health Crisis Escalates Amidst Tensions Between President Petro and Insurance Companies

15 hours ago

Colombia is experiencing a profound health crisis as the tension between President Gustavo Petro and health insurance companies reaches a boiling point. This confrontation is leading to widespread uncertainty for millions of Colombians who rely on healthcare services. The crux of the crisis lies in the conflicts surrounding healthcare policies and the functioning of the health insurance system, which many argue is under severe strain.

UnitedHealthcare’s New CEO Discusses Overcoming Challenges in First Interview

15 days ago

In an exclusive first interview, Andrew Witty, the newly appointed CEO of UnitedHealthcare, opened up about the personal tragedies that have shaped his journey and the formidable challenges he faces leading one of the largest health insurance companies in the United States. Witty, who took over the helm at a turbulent time for the healthcare industry, expressed a mix of motivation and resolve to navigate the complex landscape ahead.

HIV Funding Crisis Sparks Worry Over Increased Risk of Airborne Diseases

2 months ago

Amid a concerning lack of support for HIV initiatives, experts are sounding alarms about the potential rise in airborne diseases, linking the deterioration of funding and resources directly to the health risks communities may face. The situation has escalated to a point where experts warn that the focus on HIV has diminished significantly, leaving gaps that could lead to an uptick in other infectious diseases.

UN Official Critiques World Bank's Support for Private Hospitals at Davos

2 months ago

During this year's prestigious World Economic Forum in Davos, Switzerland, a United Nations spokesperson voiced strong opposition against the World Bank's funding of private hospitals in low-income countries. The remarks were made amid mounting concerns regarding healthcare access and equity globally.

Roche's Bold $1 Billion Investment to Make Gene Therapies Affordable

5 months ago

In a groundbreaking move within the biotechnology sector, Roche has announced a remarkable investment of $1 billion aimed at making gene therapies more accessible and affordable. This high-stakes initiative comes in response to the widespread concern regarding the exorbitant costs associated with gene treatments, which have often barred patients from receiving potentially life-saving therapies.